Residual Symptoms in MDD
neuroscienceCME Webcast
Premiere Date: Wednesday, March 23, 2016This activity offers CE credit for:
- Physicians (CME)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, March 23, 2017
Note: Credit Is No Longer Available
 | David C. Steffens, MD, MHS Professor and Chair Department of Psychiatry University of Connecticut Health Center Farmington, CT |
This video is a replay of a plenary session from the 8th Annual Chair Summit Master Class for Neuroscience Professional Development held in Miami Florida on September 24-26, 2015.
At the end of this CE activity, participants should be able to:
- Engage the patient to develop a treatment strategy that addresses the cognitive and residual symptoms of depression
- Initiate a treatment plan that includes the latest pharmacotherapeutic options for the treatment of MDD
- Routinely administer symptom assessment tools with patients with MDD to monitor clinical change over time.
This activity is supported by an educational grant from Allergan, Inc.
Physicians, physician assistants, nurse practitioners, and other nonphysician health care professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Credit (Physicians): CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST20113 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr Steffens has the following disclosures:
Consultant: Janssen Research & Development, LLC
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Robert Kennedy (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
CHV-035-030916-03
